Document Detail


Neuroticism but not omega-3 fatty acid levels correlate with early responsiveness to escitalopram.
MedLine Citation:
PMID:  20680188     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Omega-3 fatty acid (O3FA) levels and dimensional personality measures have been associated with major depression and the course of depressive illness. We sought to study the utility of O3FA levels and dimensional personality measures as predictors of early improvement with escitalopram.
METHODS: Twenty-four participants were enrolled in an open-label trial of escitalopram 10 mg/d for 4 weeks. Baseline erythrocyte O3 levels and dimensional personality assessments were obtained.
RESULTS: Using a conservative, intention-to-treat analysis, baseline neuroticism (r = -0.57; P = .007), as measured by the Revised NEO Personality Inventory but not erythrocyte O3 levels, was correlated with improvements on escitalopram. A facet analysis of the neuroticism domain showed the relationship with antidepressant response to be focused on trait anxiety (r = -0.65; P = .002).
CONCLUSIONS: Anxiety may have important prognostic implications on subsequent response to selective serotonin reuptake inhibitors, such as escitalopram.
Authors:
Jess G Fiedorowicz; Nancy Hale; Arthur A Spector; William H Coryell
Related Documents :
18024088 - Treatment of aggression with topiramate in male borderline patients, part ii: 18-month ...
2056418 - Dimensions of alexithymia and their relationships to anxiety and depression.
19382138 - Evidence for an association of the big five personality factors with recurrence of depr...
19322938 - The evolution of reciprocity in sizable human groups.
1408668 - Patellar band for patellofemoral disorders: results and indications.
18793398 - Design and methods for a randomized clinical trial treating comorbid obesity and major ...
Publication Detail:
Type:  Controlled Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists     Volume:  22     ISSN:  1547-3325     ISO Abbreviation:  Ann Clin Psychiatry     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-08-03     Completed Date:  2011-01-04     Revised Date:  2011-09-26    
Medline Journal Info:
Nlm Unique ID:  8911021     Medline TA:  Ann Clin Psychiatry     Country:  United States    
Other Details:
Languages:  eng     Pagination:  157-63     Citation Subset:  IM    
Affiliation:
Departments of Psychiatry and Epidemiology, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA. jess-fiedorowicz@uiowa.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antidepressive Agents, Second-Generation / adverse effects,  therapeutic use*
Anxiety Disorders / blood,  drug therapy,  psychology
Character*
Citalopram / adverse effects,  therapeutic use*
Depressive Disorder, Major / blood,  drug therapy*,  psychology
Erythrocytes / metabolism
Fatty Acids, Omega-3 / blood*
Female
Humans
Male
Middle Aged
Neurotic Disorders / blood,  drug therapy*,  psychology
Personality Inventory / statistics & numerical data*
Prognosis
Prospective Studies
Psychometrics
Treatment Outcome
Grant Support
ID/Acronym/Agency:
1K23MH083695-01A210/MH/NIMH NIH HHS; 3 UL1 RR024979-03S4/RR/NCRR NIH HHS; L30 MH075180-01/MH/NIMH NIH HHS
Chemical
Reg. No./Substance:
0/Antidepressive Agents, Second-Generation; 0/Fatty Acids, Omega-3; 59729-33-8/Citalopram
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis ...
Next Document:  Early improvements in anxiety, depression, and anger/hostility symptoms and response to antidepressa...